Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome
Chase, A., Bryant, C., Score, J., Cross, N. C. P.Volume:
98
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2012.066407
Date:
January, 2013
File:
PDF, 583 KB
english, 2013